Malubay, Jayeen Ellise M.

HRN: 15-40-22  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2022
CEFUROXIME 750MG (VIAL)
05/02/2022
05/08/2022
IVT
430
Q8
Pneumonitis, Urti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: